Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells

Journal of Clinical Investigation

Volumn 100, Issue 7, 1997, Pages 1734-1741

  Chaves Olarte, Esteban ^a   Weidmann, Manfred ^b   Von Eichel Streiber, Christoph ^b   Thelestam, Monica ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cultured tumor cells; Glucosyltransferase; Lung fibroblasts; Pseudomembranous enterocolitis; Ras proteins

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; GLUCOSYLTRANSFERASE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CHINESE HAMSTER; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME SPECIFICITY; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS;

EID: 0030931082     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119698     Document Type: Article

References (31)

1. von Eichel-Streiber, C., P. Boquet, M. Sauerhorn, and M. Thelestam. 1996. Large clostridial cytotoxins - a family of glycosyltransferases modifying smalt GTP-binding proteins. Trends Microbiol. 4:375-382.
2. von Eichel-Streiber, C., D. Meyer zu Heringdorf, E. Habermann, and S. Sartingen. 1995. Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. Mol. Microbiol. 17:313-321.
3. von Eichel-Streiber, C., R. Laufenberg-Feldmann, S. Sartingen, J. Schulze, and M. Sauerborn. 1992. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol. Gen. Genet. 233:260-268.
4. Frey, S.M., and T.D. Wilkins. 1992. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect. Immun. 60:2488-2492.
5. Martinez, R.D., and T.D. Wilkins. 1992. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile. J. Med. Microbiol. 36:30-36.
6. Just, I., J. Selzer, M. Wilm, C. von Eichel-Streiher, M. Mann, and K. Aktories. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (Lond.). 375:500-503.
7. Just, I., M. Wilm, J. Selzer, G. Rex, C. von Eichel-Streiber, M. Mann, and K. Aktories. 1995. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270:13932-13936.
8. Aktories, K. 1997. Bacterial toxins that target Rho proteins. J. Clin. Invest. 99:827-829.
9. Aktories, K., and I. Just. 1995. Monoglucosylation of low-molecular-mass GTP-binding Rho proteins by clostridial cytotoxins. Trends Cell Biol. 5:441-443.
10. Florin, I., and M. Thelestam. 1983. Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts. Biochim. Biophys. Acta. 763: 383-392.
11. Henriques, B., I. Florin, and M. Thelestam. 1987. Cellular internalisation of Clostridium difficile toxin A. Microb. Pathog. 2:455-463.
12. Teneberg, S., I. Lönnroth, J.F. Torres Lopez, U. Galili, M.O. Halvarsson, J. Ångström, and K.A. Karlsson. 1996. Molecular mimicry in the recognition of glycosphingolipids by Galα3Galβ4GlcNAcβ-binding Clostridium difficile toxin A, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor. Glycobiology. 6:599-609.
13. Lyerly, D.M., K.E. Saum, D.K. MacDonald, and T.D. Wilkins. 1985. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47:349-352.
14. Lyerly, D.M., and T.D. Wilkins. 1995. Clostridium difficile. In Infections of the Gastrointestinal Tract. M.J. Blaser, P.D. Smith, J.I. Ravdin, H.B. Greenberg, and R.L. Guerrant, editors. Raven Press, Ltd., New York. 867-891.
15. Tucker, K.D., P.E. Carrig, and T.D. Wilkins. 1990. Toxin A of Clostridium difficile is a potent cytotoxin. J. Clin. Microbiol. 28:869-871.
16. von Eichel-Streiber, C., U. Harperath, D. Bosse, and U. Hadding. 1987. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. Microb. Pathog. 2:307-318.
17. Shoshan, M.C., P. Aman, S. Skog, I. Florin, and M. Thelestam. 1990. Microfilament-disrupting Clostridiutn difficile toxin B causes multinucleation of transformed cells but does not block capping of membrane Ig. Eur. J. Cell Biol. 53:357-363.
18. Chaves-Olarte, E., I. Florin, P. Boquet, M. Popoff, C. von Eichel-Streiber, and M. Thelestam. 1996. UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii. J. Biol. Chem. 271:6925-6932.
19. Hames, B.D. 1976. An improved radiochemical assay for uridine diphosphoglucose pyrophosphorylase. Anal. Biochem. 73:215-219.
20. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
21. Middlebrook, J.L., R.B. Dorland, and S.H. Leppla. 1978. Association of diphtheria toxin with Vero cells: demonstration of a receptor. J. Biol. Chem. 253:7325-7330.
22. Popoff, M.R., E. Chaves-Olarte, E. Lemichez, C. von Eichel-Streiber, M. Thelestam, P. Chardin, D. Cussac, B. Antonny, P. Chavrier, G. Flatau, et al. 1996. Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation. J. Biol. Chem. 271:10217-10224.
23. Hechl, G., C. Pothoulakis, J.T. LaMont, and J.L. Madara. 1988. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J. Clin. Invest. 82:1516-1524.
24. Hecht, G., A. Koutsouris, C. Pothoulakis, J.T. LaMont, and J.L. Madara. 1992. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology. 102:416-423.
25. Florin, I., and M. Thelestam. 1986. Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb. Pathog. 1:373-385.
26. Hofmann, F., C. Busch, U. Prepens, I. Just, and K. Aktories. 1997. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J. Biol. Chem. 272:11074-11078.
27. Thelestam, M., I. Florin, and E. Chaves-Olarte. 1997. Clostridium difficile toxins. In Bacterial Toxins. K. Aktories, editor. Chapman & Hall Inc., Weinheim. 141-158.
28. Rolfe, R.D. 1991. Binding kinetics of Clostridium difficile toxins A and B to intestinal brush border membranes from infant and adult hamsters. Infect. Immun. 59:1223-1230.
29. Wilkins, T.D., and D.M. Lyerly. 1996. Clostridium difficile toxins attack Rho. Trends Microbiol. 4:49-51.
30. Castagliuolo, I., J.T. LaMont, R. Letourneau, C. Kelly, J.C. O'Keane, A. Jaffer, T.C. Theoharides, and C. Pothoulakis. 1994. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology. 107:657-665.
31. Riegler, M., R. Sedivy, C. Pothoulakis, G. Hamilton, J. Zacherl, G. Bischof, E. Cosentini, W. Feil, R. Schiessel, J.T. LaMont, et al. 1995. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J. Clin. Invest. 95:2004-2011.